Significant disparities exist in the availability and funding of CAR-T therapy for pediatric patients with B-ALL across Europe, highlighting the need for a standardized regional referral framework.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.
